Synapse - Genitourinary Oncology Service

Results (5687)

Performance characteristics of an analytic model predicting retroperitoneal lymph node dissection pathology following first-line chemotherapy for patients with metastatic non-seminomatous germ cell tumors

Journal Article

Matulewicz, R. S.; Assel, M.; Vickers, A. J.; Jayalath, V. H.; Gold, S. A.; Funt, S. A.; Feldman, D. R.; Sheinfeld, J.
Journal of Urology (2025)

Fulltext@MSK | Save

First-line pembrolizumab plus lenvatinib for advanced non–clear-cell renal cell carcinoma: Updated results from the phase 2 KEYNOTE-B61 trial

Journal Article

Voss, M. H.; Gurney, H.; Atduev, V.; Suarez, C.; Climent, M. A.; Pook, D.; Tomczak, P.; Barthélémy, P.; Lee, J. L.; Nalbandian, T.; more...
European Urology (2025)

Fulltext@MSK | Save

Baseline health-related quality-of-life metrics among patients with testicular germ cell tumours

Research Letter

Gold, S. A.; Yu, R.; Jayalath, V. H.; Baky, F.; Liso, N.; Williams, B.; Tin, A. L.; Feldman, D. R.; Funt, S. A.; Vickers, A. J.; more...
BJU International (2025)

Fulltext@MSK | Save

Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial

Journal Article

Powles, T. B.; Van der Heijden, M. S.; Loriot, Y.; Bedke, J.; Valderrama, B. P.; Iyer, G.; Kikuchi, E.; Hoffman-Censits, J.; Vulsteke, C.; Drakaki, A.; more...
Annals of Oncology (2025)

Fulltext@MSK | Save

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

Journal Article

Beckermann, K. E.; Shah, N. J.; Campbell, M. T.; Haas, N. B.; Nelson, A.; Ornstein, M. C.; Mao, S.; Keshava-Prasad, H. S.; Hammers, H.; Gao, X.; more...
The Oncologist (2025)

Fulltext@MSK | Save

Disruption of TAD hierarchy promotes LTR co-option in cancer

Journal Article

Wong, E. W. P.; Sahin, M.; Yang, R.; Lee, U.; Li, D.; Zhan, Y. A.; Misra, R.; Tomas, F.; Alomran, N.; Polyzos, A.; more...
Nature Genetics (2025)

Fulltext@MSK | Save

Comprehensive molecular, pathological, and clinical characterization of clear cell adenocarcinoma of the urinary tract

Journal Article

Rammal, R.; Koll, F. J.; Chen, Z.; Tallman, J. E.; Alam, S. M.; Eichholz, J. E.; Chatila, W.; Agbamu, T.; Lenis, A. T.; Basar, M.; more...
Modern Pathology (2025)

Fulltext@MSK | Save

Symptomatic prostate-specific membrane antigen PET–positive radionecrosis after multimodality brain metastasis–directed treatment including [(177)Lu]Lu-PSMA-617

Journal Article

Imber, B. S.; Yu, K. K. H.; Abida, W.; Pike, L. R. G.; Grkovski, M.; Kaley, T. J.; Morris, M. J.; Bodei, L.; Nosov, A.; Dunphy, M. P. S.; more...
Journal of Nuclear Medicine (2025)

Fulltext@MSK | Save

Relationship among DNA damage response gene alterations, molecular subtypes, and survival outcomes in patients with metastatic bladder cancer treated on CALGB 90601

Journal Article

Iyer, G.; Choi, W.; Luo, B.; Carvalho, F.; Hanlon, T.; Reis, H.; Guercio, B. J.; Fong, M.; Mountain, J.; Feng, M.; more...
JCO Precision Oncology (2025)

Fulltext@MSK | Save

Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictions

Journal Article

Zhang, Y.; Lev-Ari, S.; Zaemes, J.; Pia, A. D.; DeAgresta, B.; Gupta, S.; Marki, A.; Zemel, R.; Ip, A.; Alaoui, A.; more...
JAMIA Open (2025)

Fulltext@MSK | Save